Latest News about NVS
Recent news which mentions NVS
Despite Medicare Negotiations, Americans May Still Have To Pay More For Prescription Drugs
September 03, 2024
From Benzinga
From Benzinga
Siemens Healthineers To Buy Novartis Diagnostics To Bolster Cancer Scan Business In $220M Deal
August 26, 2024
From Benzinga
From Motley Fool
Judge Rules Against Novartis' Effort To Halt Generic Launch Of Its Top-Selling Heart Disease Drug
August 13, 2024
From Benzinga
FDA Approves Expanded Use Of Novartis' Rare Disease Drug Fabhalta For Kidney Disease
August 08, 2024
From Benzinga
Novartis And Viatris Sued Over Unlawful Use Of HeLa Cells Used For Cancer Treatment Drugs
August 06, 2024
From Benzinga
AstraZeneca, Sanofi And Other Pharma Giants Pursue Chinese Deals Despite Rising US-China Strife
July 23, 2024
From Benzinga
Tickers
NVS
From Motley Fool
From Benzinga
Novartis' Q2 Earnings: Revenue And EPS Beat, Raises 2024 Profit Forecast On Strong Demand For Key Drugs
July 18, 2024
From Benzinga
From Benzinga
Alnylam Stock Is a Blockbuster Biopharma In the Making
July 18, 2024
From InvestorPlace
Tickers
NVS
From InvestorPlace
2 Magnificent Stocks to Buy With $500
July 18, 2024
From Motley Fool
From Benzinga
From InvestorPlace
3 Spinoff Stocks You Should Buy Now: July 2024
July 15, 2024
From InvestorPlace
From Benzinga
From InvestorPlace
3 Healthcare Stocks Injecting AI for Big Gains
July 13, 2024
From InvestorPlace
The 3 Most Undervalued Pharma Stocks to Buy in July 2024
July 12, 2024
From InvestorPlace
Ozempic Maker Novo Nordisk Reprimanded by UK Regulators for Payment Disclosure Failures
July 05, 2024
From Benzinga
Upcoming Stock Spinoffs: Should You Pounce or Pass?
July 04, 2024
From InvestorPlace
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.